Phase IV Observational Study of Orelabrutinib in the Treatment of Chronic Lymphocytic Leukemia/Small Cell Lymphoma
Clinical trial NCT05920668 · UNKNOWN
Trial details
- NCT number
- NCT05920668
- Sponsor
- Wang Xin
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-07-01
- Primary completion
- 2024-07-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.